Public Profile

Merck Serono Middle East Fz-Ltd.

Merck Serono Middle East Fz-Ltd., a subsidiary of Merck KGaA, Darmstadt, Germany, is a prominent player in the biopharmaceutical industry, headquartered in the United Arab Emirates (AE). Established in 1668, Merck has evolved significantly, with Merck Serono focusing on innovative medicines in areas such as oncology, neurology, and fertility. With a strong operational presence across the Middle East, the company is renowned for its commitment to research and development, delivering unique therapies that address unmet medical needs. Merck Serono's core products, including cutting-edge biologics and specialty pharmaceuticals, distinguish themselves through their efficacy and safety profiles. As a leader in the biopharmaceutical sector, Merck Serono has achieved notable milestones, reinforcing its market position and dedication to improving patient outcomes across the region.

DitchCarbon Score

How does Merck Serono Middle East Fz-Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Merck Serono Middle East Fz-Ltd.'s score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

Merck Serono Middle East Fz-Ltd.'s reported carbon emissions

Merck Serono Middle East Fz-Ltd., headquartered in the United Arab Emirates (AE), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of specific emissions data, it is important to note that Merck Serono is committed to addressing climate change through various initiatives. However, details regarding specific reduction targets or commitments to the Science Based Targets initiative (SBTi) have not been disclosed. As the company continues to navigate the evolving landscape of environmental responsibility, it is likely that future disclosures will provide clearer insights into their carbon footprint and climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Merck Serono Middle East Fz-Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Merck Serono Middle East Fz-Ltd. is in AE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Merck Serono Middle East Fz-Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers